Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024
Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024
DUBLIN, Ireland and BRIDGEWATER, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Patrick Holt, President & CEO, and members of Amarin's senior management team to discuss its first quarter 2024 results followed by Q&A on Wednesday, May 1st, 2024, at 8:00 a.m. ET.
愛爾蘭都柏林和新澤西州布里奇沃特，2024年4月15日（GLOBE NEWSWIRE）——Amarin Corporation plc（納斯達克股票代碼：AMRN）今天宣佈，它將與總裁兼首席執行官帕特里克·霍爾特以及Amarin高級管理團隊成員舉行電話會議，討論其2024年第一季度業績，隨後於5月1日星期三進行問答st，2024年，美國東部時間上午8點
The conference call with management will follow the release of the Company's first quarter 2024 financial results in the pre-market hours.
與管理層的電話會議將在公司盤前公佈2024年第一季度財務業績之後舉行。
To enhance engagement with the company's shareholder base and facilitate connections with its investors, Amarin is partnering with Say Technologies to allow retail and institutional shareholders to submit and upvote questions, a selection of which will be answered by Amarin management during the earnings call.
爲了加強與公司股東群的參與度並促進與投資者的聯繫，Amarin正在與Say Technologies合作，允許散戶和機構股東提交和投票支持問題，其中一些問題將由Amarin管理層在業績電話會議上回答。
Starting on April 15th at 8:00 am ET, all shareholders are encouraged to submit questions by visiting: This Q&A platform will remain open until 48 hours prior to the start of the earnings call. Shareholders can email support@saytechnologies.com for any support inquiries.
從 4 月 15 日開始第四 美國東部時間上午8點，鼓勵所有股東通過訪問以下方式提交問題：該問答平台將一直開放至業績電話會議開始前的48小時。股東可以發送電子郵件至 support@saytechnologies.com 詢問任何支持問題。
Conference Call and Webcast Information:
電話會議和網絡直播信息：
Access to the live call:
Go to the investor relations section of the Company's website at
Dial in within the United States: 888-506-0062
International dial in: 973-528-0011
Access Code: 207947
訪問實時通話：
訪問公司網站的投資者關係部分，網址爲
在美國境內撥號：888-506-0062
國際撥號：973-528-0011
接入碼：207947
Access to replay:
Dial in within the United States: 877-481-4010
International dial in: 919-882-2331
Access Code: 50260
重播權限：
在美國境內撥號：877-481-4010
國際撥號：919-882-2331
訪問碼：50260
A replay of the call will also be available through the Company's website shortly after the call.
電話會議結束後不久，公司網站還將重播電話會議。
About Amarin
Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From our foundation in scientific research to our focus on clinical trials, and now our commercial expansion, we are evolving and growing rapidly. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk.
關於阿瑪琳
Amarin是一家創新制藥公司，引領心血管疾病管理的新模式。從我們的科學研究基礎到專注於臨床試驗，再到現在的商業擴張，我們正在迅速發展和發展。Amarin在美國新澤西州布里奇沃特、愛爾蘭都柏林、瑞士楚格和歐洲其他國家設有辦事處，並在世界各地設有商業合作伙伴和供應商。我們致力於增進對傳統療法之外的持續存在的心血管風險的科學理解，並推進對這種風險的治療。
Availability of Other Information About Amarin
Amarin communicates with its investors and the public using the company website () and the investor relations website (investor.amarincorp.com), including but not limited to investor presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference calls and webcasts. The information that Amarin posts on these channels and websites could be deemed to be material information. As a result, Amarin encourages investors, the media and others interested in Amarin to review the information that is posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on Amarin's investor relations website and may include social media channels. The contents of Amarin's website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933.
有關 Amarin 的其他信息的可用性
Amarin使用公司網站 () 和投資者關係網站（investor.amarincorp.com）與投資者和公衆進行溝通，包括但不限於投資者演示和常見問題解答、證券交易委員會文件、新聞稿、公開電話會議和網絡直播。Amarin在這些頻道和網站上發佈的信息可以被視爲重要信息。因此，Amarin鼓勵投資者、媒體和其他對Amarin感興趣的人定期查看包括投資者關係網站在內的這些渠道上發佈的信息。該渠道清單可能會在Amarin的投資者關係網站上不時更新，可能包括社交媒體頻道。根據1933年《證券法》提交的任何文件中，不應將Amarin網站或這些渠道的內容視爲以引用方式納入Amarin網站或這些渠道的任何其他網站的內容。
Amarin Contact Information
Investor & Media Inquiries:
Mark Marmur
Amarin Corporation plc
PR@amarincorp.com
Investor.relations@amarincorp.com
Amarin 聯繫信息
投資者和媒體查詢：
馬克·馬爾穆爾
阿瑪琳公司有限公司
PR@amarincorp.com
Investor.relations@amarincorp.com
譯文內容由第三人軟體翻譯。